Cargando…
De‐escalation of five‐year adjuvant endocrine therapy in patients with estrogen receptor‐low positive (immunohistochemistry staining 1%‐10%) breast cancer: Propensity‐matched analysis from a prospectively maintained cohort
BACKGROUND: The standard 5 years of endocrine therapy has demonstrated additional benefits compared with short‐term (2‐3 years) treatment in patients with estrogen receptor (ER)‐positive breast cancer; however, data specific to ER‐low positive breast cancer (1%‐10% by immunohistochemistry) are limit...
Autores principales: | Cai, Yu‐Wen, Shao, Zhi‐Ming, Yu, Ke‐Da |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9302976/ https://www.ncbi.nlm.nih.gov/pubmed/35213037 http://dx.doi.org/10.1002/cncr.34155 |
Ejemplares similares
-
Double staining immunohistochemistry
por: Chen, Xiao, et al.
Publicado: (2010) -
Characteristics of the tissue section that influence the staining outcome in immunohistochemistry
por: Libard, Sylwia, et al.
Publicado: (2018) -
Impact of adjuvant chemotherapy for radically resected esophageal squamous cell carcinoma: a propensity score matching analysis
por: Chen, Shao-bin, et al.
Publicado: (2023) -
The effect of carbon nanoparticles staining on lymph node tracking in colorectal cancer: A propensity score matching analysis
por: Liu, Fei, et al.
Publicado: (2023) -
An Image Analysis Solution For Quantification and Determination of Immunohistochemistry Staining Reproducibility
por: Chlipala, Elizabeth A., et al.
Publicado: (2020)